What iParamed does

iParamed, operating commercially under the BioSenses brand, is a Vietnam-based medical technology company that builds an Internet of Medical Things (IoMT) platform for continuous remote patient monitoring. The platform connects FDA- and CE-certified medical devices (ECG Holter, SpO2, blood pressure) to a cloud backend that synchronizes vital-sign data in real time, feeding patient-facing apps, a clinician portal, and early-warning alerts. The core technology originated during COVID-19 as a research collaboration with OUCRU (Oxford University Clinical Research Unit) and was deployed across hundreds of ICU beds, accumulating 30,000+ hours of analyzed vital-sign data and 2,000+ clinical monitoring sessions.

The company packages the underlying platform into five commercial solution lines — BIO SLEEPCARE (sleep apnea screening), BIO RHYTHM (continuous cardiovascular monitoring and risk stratification), BIO CARDICARE (multi-device cardiac and exercise screening), BIO TELECARE (remote tele-monitoring programs), and BIO RESEARCH (clinical research data platform) — and sells them as a bundled offering of hardware, software subscription, and clinical implementation services. Go-to-market is direct enterprise sales to Vietnamese hospitals and specialty clinics (sleep centers, cardiology, respiratory), supported by an advisory board of senior Vietnamese clinicians and a website-driven inside-sales funnel with 24-hour follow-up.

The business is privately held, headquartered in Vietnam, with 7 employees and no disclosed external funding, parent company, or revenue figures. Customer logos are limited (FPT Polytechnic, MedArmor, Nguyen Trai Hospital), and the full device ecosystem carries FDA, CE, and Vietnam Ministry of Health approvals — a regulatory posture that, while heavyweight for a company of this size, also signals readiness for any eventual geographic expansion beyond the single domestic market currently served.

Name

iParamed

Legal name

BioSenses

Website

https://iparamed.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

iParamed (BioSenses) is a Vietnam-based health-tech company that operates an FDA- and CE-certified IoMT platform for continuous remote patient monitoring, selling bundled hardware, software, and clinical services to hospitals and specialty clinics in Vietnam.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways) (HLAHACAH), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Remote patient monitoring
• IoMT platform
• Clinical telemedicine
• Vital sign monitoring
• Connected medical devices

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: Sale of FDA, CE certified medical devices including ECG Holter, SpO2 monitors, and blood pressure devices integrated with the platform
2. Software Platform Subscription: Cloud-based platform subscription for remote patient monitoring, data analysis, and clinical support services
3. Professional Services: Clinical implementation support, training, and professional services for healthcare facilities deploying remote monitoring solutions

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

iParamed (operating as BioSenses) provides an IoMT (Internet of Medical Things) remote health monitoring platform that integrates FDA/CE-certified medical devices (ECG Holter, SpO2, blood pressure monitors) with cloud-based software for real-time vital sign collection, synchronization, and clinical decision support. The platform enables continuous patient monitoring across hospitals, specialty clinics, and home environments, with bundled solutions covering sleep apnea screening, cardiac monitoring, tele-monitoring, and clinical research.

Product overview

iParamed, through its BioSenses platform, operates as a unified remote health monitoring ecosystem combining medical devices, IoMT connectivity, and cloud-based data management. The platform consists of a core BioSenses platform with multiple specialized solutions: BIO SLEEPCARE™ for sleep apnea screening, BIO RHYTHM™ for continuous cardiovascular monitoring, BIO CARDICARE™ for multi-device cardiac screening, BIO TELECARE™ for tele-monitoring programs, and BIO RESEARCH™ for clinical research. The closed-loop ecosystem connects medical devices to a unified platform enabling real-time vital sign collection and synchronization, supporting healthcare facilities in maintaining continuous patient monitoring from clinic to home.

Differentiator

Problem solved

Functional benefit

Products and services

• BioSenses Platform

Quantifiable outcome

• 30,000+ hours of ECG and vital sign data analyzed
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• OUCRU (Oxford University Clinical Research Unit)coreStrategic or Co-development PartnerOUCRU (Đơn vị Nghiên cứu Lâm sàng của Đại học Oxford) partnered with iParamed during COVID-19 to develop remote patient monitoring platform. This research collaboration produced the foundational technology deployed in ICU settings. OUCRU published research documentation on the platform's capabilities for disease characterization and patient management during pandemic conditions.
• Oxford UniversitycoreStrategic or Co-development PartnerOxford University through OUCRU provided clinical research validation and academic oversight for the iParamed platform development. The university's involvement established the scientific credibility and clinical evidence foundation for the technology.
• Nguyễn Trãi HospitalminorImplementation/ SI/ Consulting PartnerClinical implementation site where advisory board member Dr. Nguyễn Văn Sĩ serves as Deputy Head of Cardiology. Hospital serves as clinical expertise reference and advisory contributor for cardiovascular solutions.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• iRhythm Technologies: iRhythm is a US-based cardiac monitoring company (Zio ECG patch) that, like iParamed, focuses on continuous ECG/vital-sign capture and cloud-based clinician workflows. It is the closest direct comparable for iParamed's BIO RHYTHM and BIO CARDICARE offerings.
• VivaLNK: VivaLNK provides connected wearable vital-sign sensors (ECG, temperature, SpO2) and a platform for RPM and clinical research. It is a direct comparable on the IoMT device-and-platform stack that iParamed builds.
• Eko Health: Eko makes digital stethoscopes and connected ECG sensors with AI-assisted cardiac analysis and tele-cardiology workflows. It overlaps iParamed on FDA-cleared multi-vital devices, cloud capture, and AI clinical decision support.
• Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers BodyGuardian remote cardiac monitors and clinician monitoring services, directly comparable to iParamed's BIO RHYTHM and BIO TELECARE continuous monitoring use cases.
• AliveCor: AliveCor builds FDA-cleared, connected ECG hardware (KardiaMobile) and a clinician cloud platform, mirroring iParamed's combination of FDA-cleared medical devices and an IoMT cloud platform for cardiac assessment.
• BioTelemetry (Philips): BioTelemetry, now part of Philips, operates one of the largest remote cardiac monitoring service networks globally using connected ECG patches and Holter devices. It directly parallels iParamed's remote ECG Holter and cardiac risk-monitoring value proposition.

Emerging players

• Vitls: Vitls is a smaller startup offering a continuous remote vital-sign wearable platform focused on clinical and research use. It overlaps iParamed's IoMT continuous monitoring model at an earlier commercialization stage.

Broad incumbents

• GE HealthCare: GE HealthCare offers patient monitoring, ICU surveillance, and remote care solutions to hospitals worldwide. As a broad incumbent in hospital monitoring, it represents an alternative that established Vietnamese hospitals already buy from.
• Philips Healthcare (RPM): Philips is a global incumbent whose RPM and tele-ICU portfolio overlaps with iParamed's continuous monitoring and clinical decision support capabilities, though Philips operates across many other modalities rather than focusing on Vietnamese hospital RPM.

Regional players

• VinBrain: VinBrain is a Vietnam-based healthcare AI company serving local hospitals with imaging and clinical decision tools. It is a regional comparable because it targets the same Vietnamese hospital customer base with adjacent AI-driven clinical workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/iparamed

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iParamed